Anabolic steroids: a review for the clinician

Sports Medicine
Eric C KutscherPaul J Perry

Abstract

The number of athletes self-administering ergogenic pharmacological agents to increase their competitive edge continues to be a problem. Most athletes using anabolic steroids (AS) have acquired a crude pharmacological database regarding these drugs. Their opinions regarding steroids have been derived from their subjective experiences and anecdotal information. For this reason, traditional warnings regarding the lack of efficacy and potential dangers of steroid misuse are disregarded. A common widely held opinion among bodybuilders is that the anabolic steroid experts are the athletic gurus who for years have utilised themselves as the experimental participants and then dispensed their empirical findings. This review will address the common anabolic steroid misconceptions held by many of today's athletes by providing an evaluation of the scientific literature related to AS in athletic performance.

References

May 31, 1975·British Medical Journal·D L FreedD M Burley
Nov 1, 1975·The American Journal of Physiology·M Mayer, F Rosen
Jun 15, 1992·Biological Psychiatry·W R YatesS Murray
Jun 1, 1991·British Journal of Addiction·K J BrowerE M Hill
Jun 1, 1990·Acta Psychiatrica Scandinavica·W R YatesK H Andersen
Jul 1, 1990·The American Journal of Sports Medicine·P J PerryW R Yates
Jul 1, 1990·The American Journal of Sports Medicine·J P Jarow, L I Lipshultz
Jan 1, 1989·Journal of Drug Education·R TrickerD Cook
Jul 1, 1989·Medical Toxicology and Adverse Drug Experience·R C HicksonM T Falduto
Apr 1, 1988·The American Journal of Psychiatry·H G Pope, D L Katz
Aug 1, 1987·Seminars in Liver Disease·K G Ishak, H J Zimmerman
May 17, 1985·JAMA : the Journal of the American Medical Association·R H StraussR R Lanese
Jan 1, 1984·The American Journal of Sports Medicine·D R Lamb
Nov 1, 1984·The American Journal of Sports Medicine·H A Haupt, G D Rovere
Feb 1, 1983·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·D M CristG T Peake
May 1, 1995·Sports Medicine·C E Yesalis, M S Bahrke
May 1, 1995·The Journal of Urology·P J TurekL I Lipshultz
Jun 2, 1993·JAMA : the Journal of the American Medical Association·T P SuD R Rubinow
Mar 14, 1996·The New England Journal of Medicine·C J Bagatell, W J Bremner
Jul 4, 1996·The New England Journal of Medicine·S BhasinR Casaburi
Aug 1, 1996·The American Journal of Psychiatry·D R Rubinow, P J Schmidt
May 13, 1998·Pediatrics·A D FaigenbaumL J Micheli
Aug 26, 1998·Progress in Cardiovascular Diseases·M L SullivanE J Gallagher
Feb 19, 1999·Biological Psychiatry·W R YatesV Ellingrod
Jul 20, 1999·Clinics in Sports Medicine·J G Blue, J A Lombardo
Dec 10, 1999·Medicine and Science in Sports and Exercise·F KadiL E Thornell
May 23, 2000·Annals of Medicine·M Sheffield-Moore
Jan 12, 2001·Journal of the American College of Cardiology·M A SaderD S Celermajer
Feb 15, 2001·The Journal of the American Academy of Orthopaedic Surgeons·M D Silver
Feb 15, 2001·Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine·G A GreenC D Bray
Jun 30, 2001·The Journal of Endocrinology·M Verroken
Jun 30, 2001·The Journal of Endocrinology·R T Dawson
Dec 1, 1988·The Physician and Sportsmedicine·C E YesalisJ E Wright

❮ Previous
Next ❯

Citations

Aug 16, 2011·European Journal of Applied Physiology·Rita Cássia MarquetiHeloisa Sobreiro Selistre-de-Araujo
May 27, 2009·Internal and Emergency Medicine·Gianluca QuaglioAlessandro Lechi
Sep 17, 2002·Current Psychiatry Reports·Kirk J Brower
Jun 25, 2003·Drug and Alcohol Dependence·Gen KanayamaJames I Hudson
Aug 30, 2006·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Tom HildebrandtSteff Park
Sep 16, 2005·Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine·Paul J PerryJustin Schneider
Sep 17, 2003·Sports Medicine·Mark Juhn
Jul 14, 2004·Sports Medicine·Fred Hartgens, Harm Kuipers
Jan 31, 2009·Journal of Athletic Training·Uri FarkashMoshe Pritsch Perry
Nov 26, 2011·Canadian Journal of Physiology and Pharmacology·Tadeu Uggere AndradeNazaré Souza Bissoli
Oct 21, 2010·The Physician and Sportsmedicine·William O BrantJames F Smith
Sep 14, 2007·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Thomas A PagonisNikiforos V Angelopoulos
Mar 4, 2014·The Journal of Hand Surgery·Jayme Augusto Bertelli, Marcos Flávio Ghizoni
Dec 3, 2011·The Journal of Steroid Biochemistry and Molecular Biology·Laxmi S Inamdar Doddamani, Y Jayamma
Feb 20, 2009·Orthopedics·Seth A CheathamDarren L Johnson
Aug 29, 2007·Pediatric Clinics of North America·Julie M Kerr, Joseph A Congeni
Aug 20, 2004·Addiction·Harrison G PopeJames I Hudson
Jun 18, 2005·Anaesthesia·P C A Kam, M Yarrow
Sep 18, 2015·Frontiers in Neuroscience·Emanuela MhillajLuigia Trabace
Dec 6, 2012·Toxicology Mechanisms and Methods·Renan PozziDaniel Araki Ribeiro
May 1, 2015·Sports Medicine·Jessica SpendloveHelen O'Connor
Sep 2, 2016·High Altitude Medicine & Biology·Enrico DoneganiDavid Hillebrandt
May 27, 2008·British Journal of Pharmacology·A T Kicman
Jul 12, 2005·Toxicology Letters·C MaraveliasC Spiliopoulou
Jul 12, 2005·Clinics in Sports Medicine·Mario Ciocca
Apr 16, 2005·Primary Care·Lee Ellender, Michael M Linder
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·Paul C Carpenter
Jun 29, 2005·Emergency Medicine Clinics of North America·James T Brown
Dec 17, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Thomas A PagonisChristos S Hadjichristodoulou
Mar 2, 2017·Molecular and Cellular Endocrinology·Gen Kanayama, Harrison G Pope
Aug 2, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Francesco FurlanelloLuigi De Ambroggi
Feb 24, 2004·The American Journal of Sports Medicine·Nick A Evans
Dec 22, 2010·Substance Abuse Treatment, Prevention, and Policy·Thorolfur Thorlindsson, Vidar Halldorsson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine
Paul J PerryJustin Schneider
© 2022 Meta ULC. All rights reserved